Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a

Ido Bachelet, Ariel Munitz, Beata Berent-Maoz, David Mankuta, Francesca Levi-Schaffer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

54 Scopus citations


Through its receptor Kit (CD117), stem cell factor (SCF) critically regulates human mast cell (MC) differentiation, survival, priming, and activation. The dominance of SCF in setting these parameters compels stringent contra-regulation to maintain a balanced MC phenotype. We have synthesized a library of bispecific Ab fragments to examine the effect of linking Kit with CD300a. In this study, we report that CD300a exerts a strong inhibitory effect on Kit-mediated SCF-induced signaling, consequently impairing MC differentiation, survival, and activation in vitro. This effect derives from Kit-mediated tyrosine phosphorylation of CD300a and recruitment of the SHIP-1 but not of SH2-containing protein phosphatase 1. CD300a inhibits the constitutive activation of the human leukemic HMC-1 cells but not their survival. Finally, CD300a abrogates the allergic reaction induced by SCF in a murine model of cutaneous anaphylaxis. Our findings highlight CD300a as a novel regulator of Kit in human MC and suggest roles for this receptor as a suppressor of Kit signaling in MC-related disorders.

Original languageAmerican English
Pages (from-to)6064-6069
Number of pages6
JournalJournal of Immunology
Issue number9
StatePublished - 1 May 2008


Dive into the research topics of 'Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a'. Together they form a unique fingerprint.

Cite this